Despite nearly 200 years of fluid therapy, we continue to debate aspects of practice including the type and amount of fluid. How can this be, and are we any closer to solving these matters? Could we be inadvertently contributing to patient morbidity with our current approaches to fluid therapy?
For otherwise healthy individuals, fluid therapy is relatively straightforward. Maintenance fluid volumes and electrolyte requirements are well established for all ages. In the absence of abnormal losses, and provided that fluid in excess of that required by the kidney to excrete the daily solute load (approximately 500 ml/day in an adult) is provided, homeostasis can be maintained. When preconditions are met, the kidney adjusts body fluid balance and deals with our somewhat crude approaches to therapy.
The landmark SAFE (Saline versus Albumin Fluid Evaluation) study went most of the way in answering the question of type of fluid for the treatment of intravascular volume depletion in critically ill patients 1 . In this study there was no difference between albumin and saline with respect to the primary outcome measure, mortality, or with secondary outcomes including new organ failures, duration of mechanical ventilation, the need for renal replacement therapy and intensive care unit and hospital length-of-stay. Sub-group analysis, however, demonstrated that trauma patients resuscitated with colloid solutions had a higher mortality than those resuscitated with crystalloid solutions 2 . There was a trend towards better outcomes in patients with sepsis who were resuscitated with albumin.
For critically ill and perioperative patients, assessment of the volume of fluid required is far more complex. The patient may be faced with fluid deficits, abnormal losses and an impaired capacity to maintain homeostasis. Margins for error are reduced by pre-existing disease, systemic inflammation, increased secretion of antidiuretic hormone, disturbances of the renin-angiotensin system and natriuretic peptides. The situation may be further compounded by adherence to fixed fluid regimens or inappropriate fluid prescriptions. Inadequate fluid administration is associated with hypovolaemia, reduced tissue perfusion and ultimately shock, leading to morbidity and mortality.
By contrast, excessive fluid may precipitate pulmonary oedema and cardiac and respiratory failure. In this issue of the Journal, the study by Warrillow and colleagues retrospectively assesses fluid administration and fluid balance in elderly patients undergoing major elective gastrointestinal tract surgery 3 . The cohort of patients had a high incidence of comorbidities. Complications and outcomes are documented. Contrary to their hypothesis, much larger volumes were administered intraoperatively and in the first 24 hours postoperatively and were associated with large positive fluid balances. Overall, over 30% of patients suffered a major complication and nearly 60% at least one complication. Complications were not restricted to pulmonary congestion and oedema, but to a range of problems including severe sepsis, pneumonia, ileus, arrhythmias, delirium, abdominal sepsis and anastomotic leaks.
It is understandable that the anaesthetist may need to expand the circulatory volume to counteract the effects of anaesthesia, to compensate for hidden fluid losses and to insulate the patient against sudden blood loss. The rationale for excessive postoperative fluid administration, however, was not explored and is less clear.
It is likely that excessive fluid administration is associated not only with cardiorespiratory complications, but also a range of general surgical complications, and there is some evidence that restrictive fluid regimens may reduce morbidity, at least in major abdominal surgery 4 . Water intoxication is also the enemy of the critically ill patient. In the critical care setting there is evidence that more conservative fluid management is associated with better outcomes than liberal fluid administration in patients with acute lung injury 5 . In a randomised controlled trial, although there was no significant difference in 60-day mortality, a neutral fluid balance was associated with improved lung function and shortened duration of mechanical ventilation in intensive care compared with patients who acquired a large positive fluid balance 5 . A conservative fluid regimen was not associated with an increase in nonpulmonary organ failures.
The scientific basis of fluid therapy is well established. Too much or too little fluid is associated Editorials Fluid therapy -art or science? with morbidity and mortality. Perturbations of cardiac and renal function in particular disturb the ability of the body to control fluid status. Abnormalities of antidiuretic hormone secretion and other hormones complicate fluid dynamics in perioperative and critically ill patients. The systemic inflammatory response syndrome impairs the capacity of the body to retain fluid in the intravascular compartment. Transcapillary leakage of fluid is increased at every level of hydrostatic pressure and oncotic pressure is frequently reduced. A setting is established for significant water accumulation.
With this background, anaesthetists and intensivists must apply art as well as science to adapt fluid regimens in order to optimise fluid balance for individual patients. As a consequence, adherence to fixed fluid regimens is a recipe for disaster. In general, fluid deficits are relatively easy to manage. Fluid excess however, may require restrictive fluid regimens, diuretic therapy or at times extracorporeal fluid removal. Although haemodynamic monitoring provides some end-points for fluid therapy and resuscitation, these measures are relatively crude and in the main, applicable only to the critical care setting. Until recently, assessment of tissue perfusion and oxygen delivery has been elusive. Technologies such as near-infrared spectroscopy, Orthogonal Polarization Spectral imaging and sidestream dark field videomicroscopy are emerging in clinical practice and can be used to assess the state of the microcirculation in sepsis and shock states 6 . It remains to be seen whether these technologies can be used to fine tune fluid administration.
In the meantime, anaesthetists and intensivists should be mindful that their approach to fluid therapy can impact on a wide range of patient outcomes. The study by Warrillow and colleagues provides baseline data that can be used as a basis for prospective studies to determine whether a more restrictive approach to fluid therapy can reduce postoperative complications, particularly in elderly patients with comorbidities undergoing major surgery.
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